Stockreport

Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors
PDF WALTHAM, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today ann [Read more]